Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication

Bioorganic & Medicinal Chemistry Letters
2012.0

Abstract

3,4-Dihydropyrimidin-2(1H)-ones (DHPMs) were selected and derivatized through a HIV-1 replication assay based on GFP reporter cells. Compounds 14, 25, 31, and 36 exhibited significant inhibition of HIV-1 replication with a good safety profile. Chiral separation of each enantiomer by fractional crystallization showed that only the S enantiomer retained anti-HIV activity. Compound (S)-40, a novel and potent DHPM analog, could serve as an advanced lead for further development and the determination of the mechanism of action.

Knowledge Graph

Similar Paper

Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication
Bioorganic & Medicinal Chemistry Letters 2012.0
A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability
Bioorganic & Medicinal Chemistry Letters 2012.0
Anti-HIV Agents. Part 55: 3′R,4′R-Di-(O)-(−)-camphanoyl-2′,2′-dimethyldihydropyrano[2,3-f]chromone (DCP), a Novel Anti-HIV agent
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and in vitro antiviral evaluation of 4-substituted 3,4-dihydropyrimidinones
Bioorganic & Medicinal Chemistry Letters 2017.0
An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV
Bioorganic & Medicinal Chemistry 2010.0
Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR
Bioorganic & Medicinal Chemistry 2017.0
Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry 2014.0
Diarylpyrimidine−Dihydrobenzyloxopyrimidine Hybrids: New, Wide-Spectrum Anti-HIV-1 Agents Active at (Sub)-Nanomolar Level
Journal of Medicinal Chemistry 2011.0